|
NBIX
|
Neurocrine Biosciences, Inc.
|
1.61%
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
1.59%
|
US
|
NASDAQ
|
|
HSIC
|
Henry Schein, Inc.
|
1.59%
|
US
|
NASDAQ
|
|
DXCM
|
DexCom, Inc.
|
1.59%
|
US
|
NASDAQ
|
|
INCY
|
Incyte Corporation
|
1.57%
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
1.57%
|
US
|
NASDAQ
|
|
PINC
|
Premier, Inc.
|
1.56%
|
US
|
NASDAQ
|
|
UTHR
|
United Therapeutics Corporation
|
1.55%
|
US
|
NASDAQ
|
|
DGX
|
Quest Diagnostics Incorporated
|
1.55%
|
US
|
NYSE
|
|
A
|
Agilent Technologies, Inc.
|
1.54%
|
US
|
NYSE
|
|
GMED
|
Globus Medical, Inc.
|
1.52%
|
US
|
NYSE
|
|
HUM
|
Humana Inc.
|
1.50%
|
US
|
NYSE
|
|
EXAS
|
Exact Sciences Corporation
|
1.49%
|
US
|
NASDAQ
|
|
THC
|
Tenet Healthcare Corporation
|
1.33%
|
US
|
NYSE
|
|
SYK
|
Stryker Corporation
|
1.30%
|
US
|
NYSE
|
|
OGN
|
Organon & Co.
|
1.30%
|
US
|
NYSE
|
|
ELAN
|
Elanco Animal Health Incorporated
|
1.29%
|
US
|
NYSE
|
|
PEN
|
Penumbra, Inc.
|
1.29%
|
US
|
NYSE
|
|
MDT
|
Medtronic Inc.
|
1.29%
|
US
|
NYSE
|
|
ABBV
|
AbbVie Inc.
|
1.28%
|
US
|
NYSE
|